Omicron variant, Vaia: “Agreement to test South African vaccine”

Omicron variant of the covid, “the South African colleagues ask the Spallanzani Institute to collaborate in the experimentation of a new ‘mRna adaptive’ vaccine that they are patenting there. We will meet in January and we will start with the experimentation in Italy”. This was announced by the director of the Inmi Spallanzani of Rome, Francesco Vaia, on the sidelines of the Christmas greetings to the employees of the institute. “It is a vaccine against Omicron – Vaia specified – because it was born there in South Africa. This is good news”.